Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Higgins

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
The American Journal of Surgical Pathology|January 29, 2008
hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signatureJacques Lapointe, Sameer Malhotra, John P Higgins, et al.
Cancer Research|February 23, 2012
Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20/Rnf40) leads to replication stress and chromosomal instabilitySophia B Chernikova, Olga V Razorenova, John P Higgins, et al.
Transplantation|December 27, 2005
Combined use of the JAK3 inhibitor CP-690,550 with mycophenolate mofetil to prevent kidney allograft rejection in nonhuman primatesDominic C Borie, Michael J Larson, Mona G Flores, et al.
Pediatric Nephrology (Berlin, Germany)|October 12, 2020
Progression of proliferative glomerulonephritis with monoclonal IgG deposits in pediatric patientsPaul Miller, Andrew Y Xiao, Vanderlene L Kung, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2004
Gene expression profiling identifies clinically relevant subtypes of prostate cancerJacques Lapointe, Chunde Li, John P Higgins, et al.
The Journal of Clinical Investigation|September 19, 2006
Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritisRicardo T Paniagua, Orr Sharpe, Peggy P Ho, et al.
The American Journal of Surgical Pathology|September 29, 2015
Eosinophilic, Solid, and Cystic Renal Cell Carcinoma: Clinicopathologic Study of 16 Unique, Sporadic Neoplasms Occurring in WomenKiril Trpkov, Ondrej Hes, Michael Bonert, et al.
Transplantation|April 9, 2005
Immunosuppression by the JAK3 inhibitor CP-690,550 delays rejection and significantly prolongs kidney allograft survival in nonhuman primatesDominic C Borie, Paul S Changelian, Michael J Larson, et al.
The American Journal of Surgical Pathology|August 6, 2014
Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patientsJuan Guo, Maria S Tretiakova, Megan L Troxell, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
The American Journal of Surgical Pathology|January 29, 2008
hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signatureJacques Lapointe, Sameer Malhotra, John P Higgins, et al.
Cancer Research|February 23, 2012
Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20/Rnf40) leads to replication stress and chromosomal instabilitySophia B Chernikova, Olga V Razorenova, John P Higgins, et al.
Transplantation|December 27, 2005
Combined use of the JAK3 inhibitor CP-690,550 with mycophenolate mofetil to prevent kidney allograft rejection in nonhuman primatesDominic C Borie, Michael J Larson, Mona G Flores, et al.
Pediatric Nephrology (Berlin, Germany)|October 12, 2020
Progression of proliferative glomerulonephritis with monoclonal IgG deposits in pediatric patientsPaul Miller, Andrew Y Xiao, Vanderlene L Kung, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2004
Gene expression profiling identifies clinically relevant subtypes of prostate cancerJacques Lapointe, Chunde Li, John P Higgins, et al.
The Journal of Clinical Investigation|September 19, 2006
Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritisRicardo T Paniagua, Orr Sharpe, Peggy P Ho, et al.
The American Journal of Surgical Pathology|September 29, 2015
Eosinophilic, Solid, and Cystic Renal Cell Carcinoma: Clinicopathologic Study of 16 Unique, Sporadic Neoplasms Occurring in WomenKiril Trpkov, Ondrej Hes, Michael Bonert, et al.
Transplantation|April 9, 2005
Immunosuppression by the JAK3 inhibitor CP-690,550 delays rejection and significantly prolongs kidney allograft survival in nonhuman primatesDominic C Borie, Paul S Changelian, Michael J Larson, et al.
The American Journal of Surgical Pathology|August 6, 2014
Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patientsJuan Guo, Maria S Tretiakova, Megan L Troxell, et al.
Pageof 10